The approval expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic ...

Glenmark Pharma launches epinephrine injection USP in US market: Our Bureau, Mumbai Tuesday, December 23, 2025, 14:15 Hrs [IST] Glenmark Pharmaceuticals Inc., USA (Glenmark) annou ...

Epinephrine Injection in a 30 mg per 30 mL Multi-Dose Vial is now available from Fresenius Kabi, expanding the company’s offerings of Epinephrine Injection. In December 2024, Fresenius Kabi introduced ...

According to IQVIA ® U.S. annual sales for epinephrine injection single- and multi-dose vials for the 12 months ended October 2025 were approximately $118 million.

The company said that its Epinephrine Injection is bioequivalent and therapeutically equivalent to the reference listed drug, ...

June 19, 2010 — A shortage of EPINEPHrine prefilled syringes may cause serious medication errors, with 1 death reported from an overdose of EPINEPHrine, according to a National Alert for Serious ...

A patient in Canada recently died after receiving an injection of epinephrine 1:1,000 from a syringe that a surgical nurse and surgeon thought contained a local anesthetic. Staff at the hospital where ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial. Glenmark's Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial. Glenmark’s epinephrine injection USP, 10 mg/10 mL (1 mg/mL) ...